100 related articles for article (PubMed ID: 1697278)
1. [Physico-chemical characterization of human seminal plasma specific antigen p30].
Hou Y; Wu M
Hua Xi Yi Ke Da Xue Xue Bao; 1990 Jun; 21(2):121-4. PubMed ID: 1697278
[TBL] [Abstract][Full Text] [Related]
2. [On the electrophoretic heterogeneity of gamma-seminoprotein (gamma-Sm)--forensic immunological studies of body fluids and secretions, report XXVIII].
Akiyama K; Tsuda R; Hara M
Nihon Hoigaku Zasshi; 1987 Oct; 41(5):412-7. PubMed ID: 2451049
[No Abstract] [Full Text] [Related]
3. Seminal plasma protein p30: simplified purification and evidence for identity with prostate specific antigen.
Sensabaugh GF; Blake ET
J Urol; 1990 Dec; 144(6):1523-6. PubMed ID: 1700162
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of antigens recognized by anti-gamma-seminoprotein antibody and anti-prostate-specific antigen antibody by means of Ouchterlony method and western blotting method].
Deguchi T; Matsui H; Ehara H; Kobayashi K; Saito I; Shinoda I; Takahashi Y; Kuriyama M; Ban Y; Kawada Y
Nihon Hinyokika Gakkai Zasshi; 1989 Mar; 80(3):349-52. PubMed ID: 2471864
[TBL] [Abstract][Full Text] [Related]
5. [Isolation and purification of p30 from human seminal plasma].
Hou YP; Wu MY
Hua Xi Yi Ke Da Xue Xue Bao; 1987 Dec; 18(4):357-60. PubMed ID: 2452782
[No Abstract] [Full Text] [Related]
6. Identity of prostate specific antigen and the semen protein P30 purified by a rapid chromatography technique.
Graves HC; Kamarei M; Stamey TA
J Urol; 1990 Dec; 144(6):1510-5. PubMed ID: 1700160
[TBL] [Abstract][Full Text] [Related]
7. Ultrastructural localizations of beta-microseminoprotein, a prostate-specific antigen, in human prostate and sperm: comparison with gamma-seminoprotein, another prostate-specific antigen.
Ito Y; Tsuda R; Kimura H
J Lab Clin Med; 1989 Sep; 114(3):272-7. PubMed ID: 2475560
[TBL] [Abstract][Full Text] [Related]
8. [Studies on prostate specific antigen, gamma-seminoprotein (gamma-Sm) as a tumor marker of prostatic cancer].
Kamachi S; Sakurabayashi I; Kawai T
Rinsho Byori; 1984 Jul; 32(7):781-5. PubMed ID: 6389940
[No Abstract] [Full Text] [Related]
9. [Benign prostatic hypertrophy with high levels of gamma-seminoprotein (gamma-Sm), prostate specific antigen: report of two cases].
Asakawa M; Yasumoto R; Kamizuru M; Maekawa M
Hinyokika Kiyo; 1988 Dec; 34(12):2189-91. PubMed ID: 2467544
[TBL] [Abstract][Full Text] [Related]
10. [On the chymotrypsin-like activity of prostate specific antigen, gamma-seminoprotein (gamma-Sm)--forensic immunological studies of body fluids and secretions, Report XXXV].
Akiyama K; Nakamura T; Iwanaga S; Hara M
Nihon Hoigaku Zasshi; 1988 Apr; 42(2):154-60. PubMed ID: 2459431
[No Abstract] [Full Text] [Related]
11. [Correlation of serum gamma-seminoprotein and serum prostate-specific antigen in patients with prostate cancer].
Deguchi T; Kuriyama M; Shinoda I; Okano M; Ban Y; Kawada Y; Matsui H; Yamada A; Tada K; Kobayashi K
Nihon Hinyokika Gakkai Zasshi; 1989 Oct; 80(10):1497-501. PubMed ID: 2481057
[TBL] [Abstract][Full Text] [Related]
12. Two prostate-specific antigens, gamma-seminoprotein and beta-microseminoprotein.
Hara M; Kimura H
J Lab Clin Med; 1989 May; 113(5):541-8. PubMed ID: 2654306
[TBL] [Abstract][Full Text] [Related]
13. [Immunohistochemical localizations of gamma-seminoprotein and beta-microseminoprotein in human prostatic tissue--forensic immunological studies of body fluids and secretion, report XXIX].
Ito Y; Yoshitake N; Tsuda R; Hara M
Nihon Hoigaku Zasshi; 1987 Oct; 41(5):418-21. PubMed ID: 2451050
[No Abstract] [Full Text] [Related]
14. Demonstration of the role of prostate-specific antigen in semen liquefaction by two-dimensional electrophoresis.
Lee C; Keefer M; Zhao ZW; Kroes R; Berg L; Liu XX; Sensibar J
J Androl; 1989; 10(6):432-8. PubMed ID: 2482840
[TBL] [Abstract][Full Text] [Related]
15. [The measurement of serum prostatic antigens (gamma-Seminoprotein and beta-Microseminoprotein by radioimmunoassay].
Okabe T; Eto K
Igaku Kenkyu; 1982 Oct; 52(3):140-3. PubMed ID: 6190342
[No Abstract] [Full Text] [Related]
16. [Changes in prostatic acid phosphatase, gamma-seminoprotein and prostate specific antigen after endocrine therapy for stage D2 prostate cancer].
Akimoto S; Akakura K; Masai M; Isaka S; Shimazaki J
Hinyokika Kiyo; 1990 Jul; 36(7):783-91. PubMed ID: 1700588
[TBL] [Abstract][Full Text] [Related]
17. [Clinical studies on tumor markers for monitoring prostate cancer patients; the evaluation of prostate-specific antigen and comparison with prostatic acid phosphatase and gamma-seminoprotein].
Shinoda I
Nihon Gan Chiryo Gakkai Shi; 1990 Nov; 25(11):2627-39. PubMed ID: 1703555
[TBL] [Abstract][Full Text] [Related]
18. [Purification of prostatic acid phosphatase and prostate specific antigen from human seminal plasma].
Aoki T; Tanaka T; Kataoka S; Horikawa H; Watabe H
Hokkaido Igaku Zasshi; 1988 Nov; 63(6):963-70. PubMed ID: 2470661
[TBL] [Abstract][Full Text] [Related]
19. Prostate-specific antigen, p30, gamma-seminoprotein, and E1.
Wang MC; Papsidero LD; Chu TM
Prostate; 1994; 24(2):107-10. PubMed ID: 7508620
[No Abstract] [Full Text] [Related]
20. Histochemical study of R1881-binding protein, prostatic acid phosphatase, prostate-specific antigen, and r-seminoprotein in prostatic cancer.
Ito H; Yamaguchi K; Sumiya H; Matsuzaki O; Shimazaki J
Eur Urol; 1986; 12(1):49-53. PubMed ID: 2419136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
